Enantioselective synthesis of NK-1 receptor antagonists (+)-CP-99,994 and (+)-CP-122,721

Tetrahedron Letters

Volumn 43, Issue 44, 2002, Pages 7979-7982

  Yamazaki, Naoki ^a   Atobe, Masakazu ^a   Kibayashi, Chihiro ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Chiral oxime ethers; CP 122,721; CP 99,994; NK 1 receptor antagonist

Indexed keywords

3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; NEUROKININ 1 RECEPTOR ANTAGONIST;

ARTICLE; CHIRALITY; DRUG SYNTHESIS; ENANTIOSELECTIVITY; REDUCTION;

EID: 0037190853     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(02)01832-4     Document Type: Article

References (25)

1. von Euler V.S., Gaddum J.H. J. Physiol. 72:1931;577-583.
2. Chang M.M., Leeman S.E. J. Biol. Chem. 245:1970;4784-4790.
3. Pernow B. Pharmacol. Rev. 35:1983;85-141.
4. Nakanishi S. Physiol. Rev. 67:1987;1117-1142.
5. Vaught J. Life Sci. 43:1988;1419-1431.
6. Watson J.W., Gonsalves S.F., Fossa A.A., McLea S., Seeger T., Obach S., Andrews P.L.R. Br. J. Pharmacol. 115:1995;84-94.
7. Zaman S., Woods A.J., Watson J.W., Reynolds D.J.M., Andrews P.L.R. Neuropharmacology. 39:2000;316-323.
8. Boks G.J., Tollenaere J.P., Kroon J. Bioorg. Med. Chem. 5:1997;535-547.
9. McLean S., Ganong A., Seymour P.A., Bryce D.K., Crawford R.T., Morrone J., Reynolds L.S., Schmidt A.W., Zorn S., Watson J., Fossa A., DePasquale M., Rosen T., Nagahisa A., Tsuchiya M., Heym J. J. Pharmacol. Exp. Ther. 277:1996;900-908.
10. Yamazaki N., Atobe M., Kibayashi C. Tetrahedron Lett. 42:2001;5029-5032.
11. For the asymmetric synthesis of (+)-CP-99,994, see: (a) Desai, M. C.; Lefkowitz, S. L.; Thadeio, P. F.; Longo, K. P.; Snider, R. M. J. Med. Chem. 1992, 35, 4911-4913; (b) Chandrasekhar, S.; Mohanty, P. K. Tetrahedron Lett. 1999, 40, 5071-5072; (c) Tsuritani, N.; Yamada, K.; Yoshikawa, N.; Shibasaki, M. Chem. Lett. 2002, 276-277.
12. For the asymmetric synthesis of (+)-CP-99,994, see: (a) Desai, M. C.; Lefkowitz, S. L.; Thadeio, P. F.; Longo, K. P.; Snider, R. M. J. Med. Chem. 1992, 35, 4911-4913; (b) Chandrasekhar, S.; Mohanty, P. K. Tetrahedron Lett. 1999, 40, 5071-5072; (c) Tsuritani, N.; Yamada, K.; Yoshikawa, N.; Shibasaki, M. Chem. Lett. 2002, 276-277.
13. For the asymmetric synthesis of (+)-CP-99,994, see: (a) Desai, M. C.; Lefkowitz, S. L.; Thadeio, P. F.; Longo, K. P.; Snider, R. M. J. Med. Chem. 1992, 35, 4911-4913; (b) Chandrasekhar, S.; Mohanty, P. K. Tetrahedron Lett. 1999, 40, 5071-5072; (c) Tsuritani, N.; Yamada, K.; Yoshikawa, N.; Shibasaki, M. Chem. Lett. 2002, 276-277.
14. For the synthesis of racemic CP-99,994, see: (a) Desai, M. C.; Thadeio, P. F.; Lefkowitz, S. L. Tetrahedron Lett. 1993, 34, 5831-5834; (b) Rosen, T.; Seeger, T. F.; Mclean, S.; Desai, M. C.; Guarino, K. J.; Bryce, D.; Pratt, K.; Heym, J. J. Med. Chem. 1993, 36, 3197-3201 (tritiated derivative).
15. For the synthesis of racemic CP-99,994, see: (a) Desai, M. C.; Thadeio, P. F.; Lefkowitz, S. L. Tetrahedron Lett. 1993, 34, 5831-5834; (b) Rosen, T.; Seeger, T. F.; Mclean, S.; Desai, M. C.; Guarino, K. J.; Bryce, D.; Pratt, K.; Heym, J. J. Med. Chem. 1993, 36, 3197-3201 (tritiated derivative).
16. For the synthesis of CP-122,721, see: Rosen, T. J.; Coffman, K. J.; McLean, S.; Crawford, R. T.; Bryce, D. K.; Gohda, Y.; Tsuchiya, M.; Nagahisa, A.; Nakane, M.; Lowe, J. A., III Bioorg. Med. Chem. Lett. 1998, 8, 281-284.
17. For reviews, see: (a) Johnson, F. Chem. Rev. 1968, 68, 375-413; (b) Hoffmann, R. W. Chem. Rev. 1989, 89, 1841-1860.
18. For reviews, see: (a) Johnson, F. Chem. Rev. 1968, 68, 375-413; (b) Hoffmann, R. W. Chem. Rev. 1989, 89, 1841-1860.
19. For recent reviews on the asymmetric addition of organometallic reagents to imines, see: (a) Enders, D.; Reinhold, U. Tetrahedron: Asymmetry 1997, 8, 1895-1946; (b) Bloch, R. Chem. Rev. 1998, 98, 1407-1438; (c) Alvaro, G.; Savoia, D. Synlett 2002, 651-673.
20. For recent reviews on the asymmetric addition of organometallic reagents to imines, see: (a) Enders, D.; Reinhold, U. Tetrahedron: Asymmetry 1997, 8, 1895-1946; (b) Bloch, R. Chem. Rev. 1998, 98, 1407-1438; (c) Alvaro, G.; Savoia, D. Synlett 2002, 651-673.
21. For recent reviews on the asymmetric addition of organometallic reagents to imines, see: (a) Enders, D.; Reinhold, U. Tetrahedron: Asymmetry 1997, 8, 1895-1946; (b) Bloch, R. Chem. Rev. 1998, 98, 1407-1438; (c) Alvaro, G.; Savoia, D. Synlett 2002, 651-673.
22. Pallavicini M., Valoti E., Villa L., Piccolo O. Tetrahedron: Asymmetry. 11:2000;4017-4025.
23. Boeckman R.K. Jr., Shao P., Mullins J.J., Minbiole K.P., Smith A.B. III. Org. Synth. 77:1999;141-152.
24. Laschat S., Kunz H. J. Org. Chem. 56:1991;5883-5889.
25. Sunazuka T., Hirose T., Shirahata T., Harigaya Y., Hayashi M., Komiyama K., Omura S. J. Am. Chem. Soc. 122:2000;2122-2123.